Rezolute
Rezolute is a late-stage biopharmaceutical company based in Bend, Oregon, focused on developing transformative therapies for rare diseases with significant unmet medical needs. With a strong commitment to patient-centered decision-making, the company aims to empower individuals affected by hyperinsulinism, a condition that can cause dangerously low blood sugar levels.
Specializing in both congenital hyperinsulinism and tumor hyperinsulinism, Rezolute is dedicated to advancing its research and clinical trials, including the Phase III sunRIZE study of its lead candidate, Ersodetug. Through collaboration with global partners, Rezolute strives to make a meaningful impact on the lives of those affected by this complex and challenging condition.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.